Grail Stock

grail.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $2.02B

GRAIL is a healthcare company specializing in early cancer detection by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to developed a multi-cancer early detection blood test.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to Grail before its M&A, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Grail Stock Price

Forge Price 1
Price not available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Grail Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
05/06/2020 Series D $392.01MM $xx.xx $4.26B Canada Pension Plan Investment Board, Illumina, Public Sector Pension Investment Board
Price per Share
$xx.xx
Shares Outstanding
76,743,836
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canada Pension Plan Investment Board, Illumina, Public Sector Pension Investment Board
05/21/2018 Series C $300MM $xx.xx $3.2B 6 Dimensions Capital, Ally Bridge Group, Blue Pool Capital, China Merchant Securities International, Crf Investment, Hillhouse Capital Group, Huangpu River Capital, Icbc International, Sequoia Capital China, Wuxi Nextcode
Price per Share
$xx.xx
Shares Outstanding
63,144,600
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
6 Dimensions Capital, Ally Bridge Group, Blue Pool Capital, China Merchant Securities International, Crf Investment, Hillhouse Capital Group, Huangpu River Capital, Icbc International, Sequoia Capital China, Wuxi Nextcode
11/22/2017 Series B $1.24B $xx.xx $2.35B Amazon, Arch Venture Partners, Goldman Sachs, Johnson & Johnson Innovation, Mckesson Ventures
Price per Share
$xx.xx
Shares Outstanding
309,256,591
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Amazon, Arch Venture Partners, Goldman Sachs, Johnson & Johnson Innovation, Mckesson Ventures
01/08/2016 Series A $85MM $xx.xx $212.5MM Amino Capital, Arch Venture Partners, Bezos Expeditions
Price per Share
$xx.xx
Shares Outstanding
85,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Amino Capital, Arch Venture Partners, Bezos Expeditions

Grail Investors Also Invested in These Private Companies

Leadership & Board

Leadership

Gautam Kollu
Chief Commercial Officer
Matthew Young
Chief Financial Officer & Chief Operating Officer
Aaron Freidin
Chief Financial Officer

Board

Brook Byers Ph.D
Maykin Ho Ph.D
Robert Nelsen
ARCH Venture Partners
Xiangmin Cui Ph.D
Decheng Capital
Catherine Friedman
Kaye Foster
William Rastetter Ph.D
Richard Klausner MD
Illumina

Grail stock FAQs

plusminus

Can you buy Grail stock?

You can no longer buy Grail stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

How to buy Grail stock?

You can no longer buy Grail stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

Can you sell Grail stock?

You can no longer sell stock of Grail on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

How to sell Grail stock?

You can no longer sell stock of Grail on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

Is Grail a public company?

Grail is now a public company.
plusminus

What is Grail’s stock price?

The stock price of Grail is not currently available.
plusminus

What is Grail’s stock ticker symbol?

The ticker symbol of Grail is not currently available.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Grail News and Media Highlights

Point32Health to Offer Grail Cancer Early Detection Test Under Pilot Program

The health plan provider will make testing available to its own employees, followed by its approximately 2.2 million commercial members.

Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case

Caris said it has already provided materials to Illumina and should not have to indulge a "fishing expedition for irrelevant, highly sensitive details."

European Commission Adopts Interim Measure to Hold Grail Separate From Illumina

The measures are legally binding for both Illumina and Grail, and compliance with them will be monitored by a trustee to be approved by the commission.

European Commission Objects to Illumina Pushing Through Grail Purchase, Mulls Response

European regulators called Illumina's decision to finalize its purchase of Grail "unprecedented" and said they could ultimately impose financial penalties.
Browse Insights
Updated on: Dec 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.